Literature DB >> 12843144

Testosterone treatment enhances regional brain perfusion in hypogonadal men.

Nasrin Azad1, Shailesh Pitale, W Earl Barnes, Nicholas Friedman.   

Abstract

The positive effect of testosterone replacement therapy on psychosocial well-being in hypogonadal men has been demonstrated by various psychometric tests. However, there is no report available that objectively demonstrates the effect of testosterone on the function of the central nervous system in men. In this report we studied cerebral perfusion in seven hypogonadal men on testosterone replacement therapy. The blood perfusion to the central nervous system was assessed using single-photon emission-computed tomography. (99 m)Tc-hexamethyl-propylene-amine oxime crosses the blood brain barrier and localizes in brain tissue, depending on the intensity of the local blood flow. Psychosocial well-being was assessed with an Androgen Deficiency in Aging Men questionnaire. The study demonstrated that testosterone replacement enhanced cerebral perfusion in midbrain and superior frontal gyrus (Brodman area 8) at 3-5 wk of treatment. At 12-14 wk the study continued to show increased perfusion in midbrain in addition to the appearance of a new activated region in the midcingulate gyrus (Brodman area 24). The results of this study provide objective evidence that testosterone and /or its metabolites increased cerebral perfusion in addition to the improvement in cognitive function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843144     DOI: 10.1210/jc.2002-020632

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial.

Authors:  Fred Sattler; Shalender Bhasin; Jiaxiu He; Chih-Ping Chou; Carmen Castaneda-Sceppa; Kevin Yarasheski; Ellen Binder; E Todd Schroeder; Miwa Kawakubo; Anqi Zhang; Ronenn Roubenoff; Stanley Azen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-11-08       Impact factor: 6.053

2.  Testosterone-related cortical maturation across childhood and adolescence.

Authors:  Tuong-Vi Nguyen; James McCracken; Simon Ducharme; Kelly N Botteron; Megan Mahabir; Wendy Johnson; Mimi Israel; Alan C Evans; Sherif Karama
Journal:  Cereb Cortex       Date:  2012-05-22       Impact factor: 5.357

Review 3.  Sexual function in men undergoing androgen deprivation therapy.

Authors:  G Corona; S Filippi; P Comelio; N Bianchi; F Frizza; M Dicuio; G Rastrelli; S Concetti; A Sforza; L Vignozzi; M Maggi
Journal:  Int J Impot Res       Date:  2021-03-21       Impact factor: 2.896

4.  Effect of Testosterone Replacement Therapy on Cognitive Performance and Depression in Men with Testosterone Deficiency Syndrome.

Authors:  Hyun Jin Jung; Hong Seok Shin
Journal:  World J Mens Health       Date:  2017-01-23       Impact factor: 5.400

5.  [Testosterone and psyche].

Authors:  C Leiber; U Wetterauer; M Berner
Journal:  Urologe A       Date:  2010-01       Impact factor: 0.639

Review 6.  Risks and benefits of testosterone therapy in older men.

Authors:  Matthew Spitzer; Grace Huang; Shehzad Basaria; Thomas G Travison; Shalender Bhasin
Journal:  Nat Rev Endocrinol       Date:  2013-04-16       Impact factor: 43.330

Review 7.  Androgen therapy in the aging male.

Authors:  Bruno Lunenfeld
Journal:  World J Urol       Date:  2003-10-24       Impact factor: 4.226

Review 8.  Testosterone deficiency in the aging male.

Authors:  J Abram McBride; Culley C Carson; Robert M Coward
Journal:  Ther Adv Urol       Date:  2016-02

9.  Effects of sex and normal aging on regional brain activation during verbal memory performance.

Authors:  Erin A Hazlett; William Byne; Adam M Brickman; Effie M Mitsis; Randall Newmark; M Mehmet Haznedar; Danielle T Knatz; Amy D Chen; Monte S Buchsbaum
Journal:  Neurobiol Aging       Date:  2008-11-21       Impact factor: 4.673

Review 10.  The many faces of testosterone.

Authors:  Jerald Bain
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.